Equillium (EQ) Other Non-Current Assets (2019 - 2026)
Equillium (EQ) reported Other Non-Current Assets of $27000.0 for Q1 2026, little changed quarter-over-quarter from $27000.0 in Q4 2025.
Equillium (EQ) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Equillium (EQ) has 8 years of Other Non-Current Assets data on file, last reported at $27000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $27000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $27000.0 (changed N/A YoY), and the FY2025 annual result was $27000.0, changed N/A from the prior year.
- Other Non-Current Assets was little changed at $27000.0 in Q1 2026 per EQ's latest filing, from $27000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $145000.0 in Q1 2022 and troughed at $27000.0 in Q4 2025.
- A 5-year average of $79153.8 and a median of $79000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 611.76% in 2022, then plunged 43.04% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $104000.0 in 2022, then tumbled by 32.69% to $70000.0 in 2023, then slumped by 35.71% to $45000.0 in 2024, then plunged by 40.0% to $27000.0 in 2025, then changed by 0.0% to $27000.0 in 2026.
- Business Quant data shows EQ's Other Non-Current Assets at $27000.0 in Q1 2026, $27000.0 in Q4 2025, and $45000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 79,000.00 |
| Jun 30, 2023 | 87,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | 104,000.00 |
| Sep 30, 2022 | 113,000.00 |
| Jun 30, 2022 | 121,000.00 |
| Mar 31, 2022 | 145,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Dec 31, 2019 | 15,000.00 |
| Sep 30, 2019 | 15,000.00 |
| Jun 30, 2019 | 15,000.00 |